My Profile
Edit Profile
My Follows
My Wires
My Drafts
Analytics
Email Preferences
Sign Out
home
Latest
Shares
ETFs
Infrastructure
Markets
Buy Hold Sell
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Ask an Adviser
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Contributors
Find Funds
Newsletter
About Livewire
Advertising
Careers
Contact Us
Write a Wire
Notifications
Loading...
Write a wire
Account
My profile
My follows
My wires
My drafts
Analytics
Email preferences
Company
About Livewire
Advertising
Contact us
Sign out
Sign In
Join Free
Latest
Shares
ETFs
Infrastructure
Markets
Buy Hold Sell
Find funds
Newsletter
Topics
Alternatives
Exchange Traded Funds (ETFs)
Growth
Income
Markets
Property
Retirement
Shares
Wealth
Shows
Ask an Adviser
Buy Hold Sell
Expert Insights
Fund in Focus
Rapid Fire
Success and More Interesting Stuff
The Rules of Investing
Series
Listed Series
Livewire Live
Meet The Investor
Outlook Series
Reporting Season
Categories
Asset Allocation
Commodities
Daily Report
Education
Equities
Fixed Income
Funds
Investment Theme
Macro
Private Markets
Property
Weekend Report
Find Funds
Contributors
Newsletter
About Livewire
Advertising
Careers
Contact Us
ASX Live Blog
Market Wraps
regulatory
Latest news and analysis on regulatory
Education
May 22, 2026 21:21
The fee spread question ASIC is asking — and private credit investors should too
Same net return. Very different risk. The gap between what borrowers pay and investors receive matters more than many investors realise.
Patrick William
Rixon Capital
May 22, 2026 21:21
Equities
November 03, 2025 13:32
An open letter to The Hon. Dr. Jim Chalmers MP
The preliminary decision to block Cosette's acquisition of Mayne Pharma sets a bad precedent and would weaken Australia's capital markets.
MYX
Mayne Pharma Group Ltd
ASX:MYX
Followed by
37
people
MYX
Mayne Pharma Group Ltd
ASX:MYX
Followed by
37
people
Luke Cummings
Harvest Lane Asset Management
November 03, 2025 13:32
2
most
popular
Equities
Question everything
Martin Conlon,
Schroders
Property
David Jones – The Final Markdown
Julian Campbell-Wood,
Resolution Capital
Shares
What Woodside’s new dividend policy means for income investors
Tim Zhao,
Lazard Asset Management
Buy Hold Sell
Buy Hold Sell: 6 ASX stocks built to handle tough
conditions
Patrick Poke,
Livewire Markets
view all
Advertisement